Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells

Cell Growth and Differentiation

Volumn 8, Issue 12, 1997, Pages 1267-1276

  Garcia, Roy ^a,b   Yu, Chao Lan ^a,b   Hudnall, Anne ^a,b   Catlett, Robyn ^a,b   Nelson, Kristie L ^c   Smithgall, Thomas ^c   Fujita, Donald J ^d   Ethier, Stephen P ^e   Jove, Richard ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; NEU DIFFERENTIATION FACTOR; ONCOPROTEIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; VIRUS LARGE T ANTIGEN; VIRUS MIDDLE T ANTIGEN;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL TRANSFORMATION; CONTROLLED STUDY; DNA BINDING; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; HUMANS; MICE; MICE, INBRED BALB C; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

ANIMALIA; POLYOMAVIRUS; RODENTIA;

EID: 0031443156     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Darned, J. E., Kerr, I. M., and Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (Washington DC), 264; 1415-1421, 1994.
2. Schindler, C., and Darnell, J. E. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Anna Rev. Biochem., 64: 621-651, 1995.
3. Ruff-Jamison, S., Chen, K., and Cohen, S. Induction by EGF and interferon-γ of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science (Washington DC), 261: 1733-1736, 1993.
4. Fu, X. Y., and Zhang, J. J. Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter. Cell, 74: 1135-1145, 1993.
5. Zhong, Z., Wen, Z., and Darnell, J. E. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science (Washington DC), 264: 95-98, 1994.
6. Leaman, D. W., Pisharody, S., Flickinger, T. W., Commane, M. A., Schlessinger, J., Kerr, I. M., Levy, D. E., and Stark, G. R. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol. Cell. Biol., 16: 369-375, 1996.
7. Vignais, M-L., Sadowski, H. B., Watling, D., Rogers, N. C., and Gilman, M. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol. Cell. Biol., 16: 1759-1769, 1996.
8. Yu, C-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., and Jove, R. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science (Washington DC), 269: 81-83, 1995.
9. Cao, X., Tay, A., Guy, G. R., and Tan, Y. H. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol. Cell. Biol., 16: 1595-1603, 1996.
10. Migone, T. S., Lin, J. X., Cereseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G., and Leonard, W. J. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science (Washington DC), 269: 79-81, 1995.
11. Danial, N. N., Pernis, A., and Rothman, P. B. Jak-STAT signaling induced by the v-abl oncogene. Science (Washington DC), 269: 1875-1877, 1995.
12. Carlesso, N., Frank, D. A., and Griffin, J. D. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med., 183: 811-820, 1996.
13. Weber-Nordt, R. M., Egen, C., Wehinger, J., Ludwig, W., Gouilleux-Gruart, V., Mertelsmann, R., and Finke, J. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood, 88: 809-816, 1996.
14. Gouilleux-Gruart, V., Gouilleux, F., Desaint, C., Claisse, J. F., Capiod, J. C., Delobel, J., Weber-Nordt, R., Dusanter-Fourt, I., Dreyfus, F., Groner, B., and Prin, L. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood, 87: 1692-1697, 1996.
15. Zhang, Q., Nowak, I., Vonderheid, E. C., Rook, A. H., Kadin, M. E., Nowell, P. C., Shaw, L. M., and Wasik, M. A. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for Interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc. Natl. Acad. Sci. USA, 93: 9148-9153, 1996.
16. Khazaie, K., Schirrmacher, V., and Lichtner, R. B. EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev., 12: 255-274, 1993.
17. Bolen, J. B., Veillette, A., Schwartz, A. M., DeSeau, V., and Rosen, N. Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc. Natl. Acad. Sci. USA, 84: 2251-2255, 1987.
18. Garcia, R., Parikh, N. U., Saya, H., and Gallick, G. E. Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines. Oncogene, 6: 1983-1989, 1991.
19. Ottenhoff-Kalff, A. E., Rijksen, G., van Beurden, E. A. C. M., Hennipman, A., Michels, A. A., and Staal, G. E. J. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res., 52: 4773-4778, 1992.
20. c-scr with two major signaling pathways in human breast cancer. Proc. Natl. Acad. Sci. USA, 91: 83-87, 1994.
21. Muthuswamy, S. K., and Muller, W. J. Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor. Oncogene, 11: 271-279, 1995.
22. Maa, M-C., Leu, T-H., McCarley, D. J., Schatzman, R. C., and Parsons, S. J. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. Proc. Natl. Acad. Sci. USA, 92: 6981-6985, 1995.
23. Jove, R., Mayer, B. J., Iba, H., Laugier, D., Poirier, F., Calothy, G., Hanafusa, T., and Hanafusa, H. Genetic analysis of p60v-src domains involved in the induction of different cell transformation parameters. J. Virol., 60: 840-848, 1986.
24. Wagner, B. J., Hayes, T. E., Hoban, C. J., and Cochran, B. H. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J., 9: 4477-4484, 1990.
25. Pallard, C., Gouilleux, F., Charon, M., Groner, B., Gisselbrecht, S., and Dusanter-Fourt, I. Interleukin-3, erythropoietin, and prolactin activate a STAT5-like factor in lymphoid cells. J. Biol. Chem., 270: 15942-15945, 1995.
26. Seidel, H. M., Milocco, L. H., Lamb, P., Darnell, J. E., Jr., Stein, R. B., and Rosen, J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc. Natl. Acad. Sci. USA, 92: 3041-3045, 1995.
27. Ruff-Jamison, S., Chen, K., and Cohen, S. Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat5 in mouse liver. Proc. Natl. Acad. Sci. USA, 92: 4215-4218, 1995.
28. Ram, T. G., Kokeny, K. E., Dilts, C. A., and Ethier, S. P. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells. J. Cell. Physiol., 163: 589-596, 1995.
29. Rewcastle, G. W., Palmer, B. D., Thompson, A. M., Bridges, A. J., Cody, D. R., Zhou, H., Fry, D. W., McMichael, A., and Denny, W. A. Tyrosine kinase inhibitors. 10. Isomeric 4-[(bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor. J. Med. Chem., 39: 1823-1835, 1996.
30. Campbell, G. S., Yu, C-L, Jove, R., and Carter-Su, C. Constitutive activation of JAK1 in Src-transformed cells. J. Biol. Chem., 272: 2591-2594, 1997.
31. Courtneidge, S. A. Protein tyrosine kinases, with emphasis on the Src family. Semin. Cancer Biol., 5: 239-246, 1994.
32. Carraway, K, L., III, and Cantley, L. C. A neu acquaintance for ErbB3 and ErbB4: a role for receptor heterodimerization in growth signaling. Cell, 78: 5-8, 1994.
33. Chang, H., Riese, D. J., II, Gilbert, W., Stern, D. F., and McMahan, U. J. Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature (Lond.), 387: 509-512, 1997.
34. Carraway, K. L, III, Weber, J. L, Unger, M. J., Ledesma, J., Yu, N., Gassmann, M., and Lai, C. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature (Lond.), 387: 512-516, 1997.
35. Sartor, C. I., Dziubinski, M. L, Yu, C. L., Jove, R., and Ethier, S. P. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res., 57: 978-987, 1997.
36. Watson, C. J., and Miller, W. R. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br. J. Cancer, 71: 840-844, 1995.
37. Zong, C., Yan, R., August, A., Darnell, J. E., and Hanafusa, H. Unique signal transduction of Eyk: constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase. EMBO J., 15: 4515-4525, 1996.
38. Lund, T. C., Garcia, R., Medveczky, M. M., Jove, R., and Medveczky, P. G. Activation of STAT transcription factors by herpesvirus saimiri Tip-484 requires p56lck. J. Virol., 71: 6677-6682, 1997.
39. Chaturvedi, P., Sharma, S., and Reddy, E. P. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs. Mol. Cell. Biol., 17: 3295-3304, 1997.
40. Thierfelder, W. E., van Deursen, J. M., Yamamoto, K., Tripp, R. A., Sarawar, S. R., Carson, R. T., Sangster, M. Y., Vignali, D. A. A., Doherty, P. C., Grosveld, G. C., and Ihle, J. N. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature (Lond.), 382: 171-174, 1996.
41. Kaplan, M. H., Sun, Y-L, Hoey, T., and Grusby, M. J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature (Lond.), 382: 174-177, 1996.
42. Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S-i, Nakanishi, K., Yoshida, N., Kishimoto, T., and Akira, S. Essential role of State in IL-4 signaling. Nature (Lond.), 380: 627-630, 1996.
43. Hou, X. S., Melnick, M. B., and Perrimon, N. Marelle acts downstream of the Drosophila HOP/JAK kinase and encodes a protein similar to the mammalian STATs. Cell, 84: 411-419, 1996.
44. Yu, C-L, Prochownik, E. V., Imperiale, M. J., and Jove, R. Attenuation of serum inducibility of immediate early genes by oncoproteins in tyrosine kinase signaling pathways. Mol. Cell. Biol., 13: 2011-2019, 1993.
45. Ethier, S. P., Mahacek, M. L., Gullick, W. J., Frank, T. J., and Weber, B. L. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res., 53: 627-635, 1993.
46. Ethier, S. P., Kokeny, K. E., Ridings, J. E., and Dilts, C. A. ErbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Cancer Res., 56: 899-907, 1996.
47. Soule, H. D., Maloney, T. M., Wolman, S. R., Peterson, W. D., Brenz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., and Brooks, S. C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50: 6075-6086, 1990.